Press Releases
Tuesday, October 6, 2009
Threshold Pharmaceuticals Completes $35 million private equity financing
Monday, August 24, 2009
Ligand to Acquire Neurogen for Stock and Contingent Value Rights
Tuesday, October 6, 2009
Threshold Pharmaceuticals Completes $35 million private equity financing
Monday, August 24, 2009
Ligand to Acquire Neurogen for Stock and Contingent Value Rights
Copyright 2010 MTS Health Partners